View clinical trials related to Osteoarthritis of the Knee.
Filter by:Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.
Overall study design: A prospective, randomized, multi-center clinical studies comparing the minimal invasive and the standard surgical total knee replacement technique (control) using the Genesis II total knee system. The study will collect efficacy, safety and socio-economical data over 2 years. An additional 5 years follow-up interval is optional. The objectives (short-term follow-up) of the study are to: 1. Assess whether the improvement in Pain and Range of motion per Knee Society scoring system and VAS score. 2. Assess whether there are any differences between the surgical techniques as regards complication rate. 3. Assess whether the hospital stay and the rehabilitation time (Straight leg raise, Active/passive ROM) of the patients differs between the two techniques. 4. Assess the x-ray mechanical alignment between the two techniques. Attempts will be made to assess whether the collected peri-operative data (including incision length, blood loss, wound appearance, hospital readmissions and operative time) differs between the two surgical techniques. The primary objectives (mid-term follow-up) of the study are to: 1. Improvement in Pain and Function per Knee Society Scoring system 2. Number and Extent of Radiographic Lucencies >2mm 3. Revision and knee-related adverse events 4. Improvement in Quality-of-life via the VAS score 5 investigational sites will participate and enroll a total of approximately 250 patients over a 12 months period. Thus, each site will enroll 50 patients.
The purpose of this study is to determine whether an intraarticular injection of Ozone into the knee joint is an effective therapy for pain control in patients with osteoarthritis of the knee.